Series B funding round for Ashvattha Therapeutics raising $50M in January 2025
Series B funding round for Ashvattha Therapeutics raising $50M in January 2025
| Investor | Firm Type | Partner |
|---|---|---|
| Venture Capital |
| — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Angel | Gokul Rajaram |
| Angel | Stuart Peterson |
| Angel | Vasudev Bailey |
| Angel | Cory Levy |
| Angel | Michael Stoppelman |
| Angel | Liu Jiang |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$126M
Top Valuation
-
Ashvattha Therapeutics raised $50M in a Series B round.
The round was announced on 01/01/25.